Search Results

Initial impairment of synaptic functions, which occurs early in Alzheimer’s disease, and subsequent massive My research focus is the mechanisms of neural circuit development, function and disease."

where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease

where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease

where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease

where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease

Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb

there was not much known other than that they are huge and somehow play important roles in health and disease

cellular mechanisms by which mutations in a chloride-proton antiporter cause the renal disorder Dent’s disease

then moved to King's College London, where my interest and passion for kinases in brain health and disease

How GPCR-mediated neuropeptide signaling dictates mosquito attraction to humans, directly impacting disease

breakfast Read More 9:50 AM Welcoming Remarks Read More 10:00 AM Student Flash Presentations Health and Disease ADGRA homolog Remoulade in Drosophila Douglas Tilley ADGRF5-mediated regulation of cardiac health and disease

Terry Hebert | McGill University Translational Pharmacology & Disease Models April 16, 2026 Details Why

novel human genetic variants identified in several GPCRs associated with obesity and other metabolic diseases

Ductal carcinomas are increasingly diagnosed but identifying which will progress to invasive disease A recent study demonstrated that GPR56 in the glomerular endothelial cells promoted diabetic kidney disease

October 23-25 Download PDF Program HERE < Back to Full Agenda Student Flash Presentations Health and Disease Cognitive sciences from the University of South Florida, where he researched early-onset Alzheimer’s disease

complex workflows, accelerate discovery, and drive breakthroughs in drug development, diagnostics, and disease